JG
LUNG icon

Jefferies Group’s Pulmonx LUNG Stock Holding History

Jefferies Group’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$20M Buy
1,201,553
+306,643
+34% +$5.65M 0.17% 95
2022
Q2 		$13.2M Buy
+894,910
New +$18.4M 0.11% 146
2022
Q1 		– Sell
-1,684
Closed -$54K – 1778
2021
Q4 		$54K Buy
+1,684
New +$61.5K ﹤0.01% 1519

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Jefferies Group's LUNG Position: Q3 2022 in Review

Jefferies Group increased its Pulmonx (LUNG) stake by 34% in Q3 2022, buying an estimated $5.65M and bringing the position to 1,201,553 shares worth $20M. The position accounts for 0.17% of the portfolio, ranked #95.

Jefferies Group first reported a position in LUNG in Q4 2021 and has held it in 3 quarters since. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

  • Jefferies Group held 1,201,553 shares of Pulmonx worth $20M as of Q3 2022.
  • Jefferies Group bought 306,643 Pulmonx shares in Q3 2022, an estimated $5.65M.
  • Pulmonx made up 0.17% of Jefferies Group's portfolio in Q3 2022, its #95 holding.
  • Jefferies Group first reported a position in Pulmonx in Q4 2021 and has held it in 3 quarters since.
  • 104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.